Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'ADVANCED COLORECTAL-CANCER' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 282 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Frenkel, GD; Caffrey, PB
      A prevention strategy for circumventing drug resistance in cancer chemotherapy

      CURRENT PHARMACEUTICAL DESIGN
    2. Mathijssen, RHJ; van Alphen, RJ; Verweij, J; Loos, WJ; Nooter, K; Stoter, G; Sparreboom, A
      Clinical pharmacokinetics and metabolism of irinotecan (CPT-11)

      CLINICAL CANCER RESEARCH
    3. Habal, N; Gupta, RK; Bilchik, AJ; Yee, R; Leopoldo, Z; Ye, W; Elashoff, RM; Morton, DL
      CancerVax, an allogeneic tumor cell vaccine, induces specific humoral and cellular immune responses in advanced colon cancer

      ANNALS OF SURGICAL ONCOLOGY
    4. Catalano, V; Baldelli, AM; Giordani, P; Cascinu, S
      Molecular markers predictive of response to chemotherapy in gastrointestinal tumors

      CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
    5. Mukai, M; Moriya, H; Himeno, S; Oida, Y; Mukohyama, S; Nishi, T; Nakasaki, H; Satoh, S; Makuuchi, H
      Efficacy of oral UFT plus leucovorin therapy for colon cancer with ovarianand multiple liver metastases: Report of two cases

      ONCOLOGY REPORTS
    6. Anderson, H; Espinosa, E; Lofts, F; Meehan, M; Hutchinson, G; Price, N; Heyes, A
      Evaluation of the Chemotherapy Patient Monitor: an interactive tool for facilitating communication between patients and oncologists during the cancerconsultation

      EUROPEAN JOURNAL OF CANCER CARE
    7. Garattini, S; La Vecchia, C
      Perspectives in cancer chemotherapy

      EUROPEAN JOURNAL OF CANCER
    8. Hauns, B; Haring, B; Kohler, S; Mross, K; Unger, C
      Phase II study of combined 5-fluorouracil/Ginkgo biloba extract (GBE 761 ONC) therapy in 5-fluorouracil pretreated patients with advanced colorectal cancer

      PHYTOTHERAPY RESEARCH
    9. Barbounis, V; Koumakis, G; Vassilomanolakis, M; Demiri, M; Efremidis, AP
      Control of irinotecan-induced diarrhea by octreotide after loperamide failure

      SUPPORTIVE CARE IN CANCER
    10. Ulrich-Pur, H; Kornek, GV; Fiebiger, W; Gedlicka, C; Raderer, M; Lenauer, A; Depisch, D; Lang, F; Pidlich, J; Scheithauer, W
      Multicenter phase II trial of dose-fractionated irinotecan in patients with advanced colorectal cancer failing oxaliplatin-based first-line combination chemotherapy

      ANNALS OF ONCOLOGY
    11. Saghatchian, M; Fizazi, K; Borel, C; Ducreux, M; Ruffie, P; Le Chevalier, T; Theodore, C
      Carcinoma of an unknown primary site: A chemotherapy strategy based on histological differentiation - results of a prospective study

      ANNALS OF ONCOLOGY
    12. Bonetti, A; Zaninelli, M; Leone, R; Franceschi, T; Fraccon, AP; Pasini, F; Sabbioni, R; Cetto, GL; Sich, D; Brienza, S; Howell, SB
      Use of the ratio of time to progression following first- and second-line therapy to document the activity of the combination of oxaliplatin with 5-fluorouracil in the treatment of colorectal carcinoma

      ANNALS OF ONCOLOGY
    13. Pitot, HC; Goldberg, RM
      Future directions in adjuvant therapy for stage III colon carcinoma

      ONCOLOGY-NEW YORK
    14. Beretta, GD; Pessi, MA; Poletti, P; Mosconi, S; Labianca, R
      New drugs and combinations in the palliative treatment of colon and rectalcancer

      EUROPEAN JOURNAL OF SURGICAL ONCOLOGY
    15. Lokich, J
      Oral fluoropyrimidines: Are they the equivalent of parenteral infusional 5-fluorouracil?

      CANCER INVESTIGATION
    16. Freyer, G; Bossard, N; Romestaing, P; Mornex, F; Chapet, O; Trillet-Lenoir, V; Gerard, JP
      Addition of oxaliplatin to continuous fluorouracil, L-folinic acid, and concomitant radiotherapy in rectal cancer: The Lyon R 97-03 Phase I trial

      JOURNAL OF CLINICAL ONCOLOGY
    17. Dencausse, Y; Sturm, J; Hartung, G; Diezler, P; Edler, L; Bambach, M; Wojatschek, C; Lindemann, H; Queisser, W
      Adjuvant radio-chemotherapy in stage II-III rectal cancer with 24-hour infusion of high-dose 5-fluorouracil and folinic acid: Evaluation of feasibility

      ONKOLOGIE
    18. Crane, CH; Janjan, NA; Abbruzzese, JL; Curley, S; Vauthey, JN; Sawaf, HB; Dubrow, R; Allen, P; Ellis, LM; Hoff, P; Wolff, RA; Lenzi, R; Brown, TD; Lynch, P; Cleary, K; Rich, TA; Skibber, J
      Effective pelvic symptom control using initial chemoradiation without colostomy in metastatic rectal cancer

      INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
    19. Reigner, B; Blesch, K; Weidekamm, E
      Clinical pharmacokinetics of capecitabine

      CLINICAL PHARMACOKINETICS
    20. Bradner, WT
      Mitomycin C: a clinical update

      CANCER TREATMENT REVIEWS
    21. Gridelli, C; Di Maio, M
      Indication for venous ports in oncology comparing different experiences inEurope

      TUMORI
    22. Gil-Delgado, MA; Guinet, F; Castaing, D; Adam, R; Coeffic, D; Durrani, AKS; Bismuth, H; Khayat, D
      Prospective phase II trial of irinotecan, 5-fluorouracil, and leucovorin in combination as salvage therapy for advanced colorectal cancer

      AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
    23. Kato, T; Shimamoto, Y; Uchida, J; Ohshimo, H; Abe, M; Shirasaka, T; Fukushima, M
      Possible regulation of 5-fluorouracil-induced neuro- and oral toxicities by two biochemical modulators consisting of S-1, a new oral formulation of 5-fluorouracil

      ANTICANCER RESEARCH
    24. Kawakami, K; Omura, K; Kanehira, E; Watanabe, G
      Methylenetetrahydrofolate reductase polymorphism is associated with folatepool in gastrointestinal cancer tissue

      ANTICANCER RESEARCH
    25. Mattioli, R; Lippe, P; Recchia, F; Massacesi, C; Imperatori, L; De Filippis, S; Rosselli, M; Gattafoni, P; Casadei, V; Consales, D
      Advanced colorectal cancer in elderly patients: Tolerance and efficacy of lencovorin and fluorouracil bolus plus continuous infusion

      ANTICANCER RESEARCH
    26. Kasakura, Y; Fujii, M; Mochizuki, F; Kobayashi, M; Yamagata, M
      Clinicopathological analyses of advanced colorectal cancers of different sizes - Especially those of 20mm or less in diameter

      HEPATO-GASTROENTEROLOGY
    27. Piedbois, P; Zelek, L; Cherqui, D
      Chemotherapy of nonoperable colorectal liver metastases

      HEPATO-GASTROENTEROLOGY
    28. Pro, B; Lozano, R; Ajani, JA
      Therapeutic response to octreotide in patients with refractory CPT-11 induced diarrhea

      INVESTIGATIONAL NEW DRUGS
    29. Blanke, CD; Stipanov, M; Morrow, J; Rothenberg, M; Chinery, R; Shyr, Y; Coffey, R; Johnson, DH; Leach, SD; Beauchamp, RD
      A phase I study of vitamin E, 5-fluorouracil and leucovorin for advanced malignancies

      INVESTIGATIONAL NEW DRUGS
    30. Takimoto, CHM; Goulet, R
      The clinical pharmacology of the oral fluoropyrimidines - Introduction

      CURRENT PROBLEMS IN CANCER
    31. Andre, T; Colin, P; Louvet, C; Gamelin, E; Bouche, O; Achille, E; Colbert, N; Boaziz, C; Piedbois, P; Tubiana-Mathieu, N; Boutan-Laroze, A; Flesch, M; Billiau, V; Buyse, M; de Gramont, A
      Randomized adjuvant study comparing two schemes of 5-fluorouracil and leucovorin in stage B2 and C colon adenocarcinoma: Study design and preliminarysafety results

      SEMINARS IN ONCOLOGY
    32. Wein, A; Riedel, C; Bruckl, W; Kastl, S; Reingruber, B; Hohenberger, W; Hahn, EG
      Weekly 24-h infusion of high-dose 5-Fluorouracil (5-FU) with folinic acid (FA) in adjuvant therapy of colon canter

      ZEITSCHRIFT FUR GASTROENTEROLOGIE
    33. Sargent, DJ; Goldberg, RM; Jacobson, SD; Macdonald, JS; Labianca, R; Haller, DG; Shepherd, LE; Seitz, JF; Francini, G
      A pooled analysis of adjuvant chemotherapy for resected colon cancer in elderly patients

      NEW ENGLAND JOURNAL OF MEDICINE
    34. Fong, L; Hou, YF; Rivas, A; Benike, C; Yuen, A; Fisher, GA; Davis, MM; Engleman, EG
      Altered peptide ligand vaccination with Flt3 ligand expanded dendritic cells for tumor immunotherapy

      PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
    35. Colevas, AD; Amrein, PC; Gomolin, H; Barton, JJ; Read, RR; Adak, S; Benner, S; Costello, R; Posner, MR
      A Phase II study of combined oral uracil and ftorafur with leucovorin for patients with squamous cell carcinoma of the head and neck

      CANCER
    36. Caro, JJ; Salas, M; Ward, A; Goss, G
      Anemia as an independent prognostic factor for survival in patients with cancer - A systematic, quantitative review

      CANCER
    37. Nordin, K; Steel, J; Hoffman, K; Glimelius, B
      Alternative methods of interpreting quality of life data in advanced gastrointestinal cancer patients

      BRITISH JOURNAL OF CANCER
    38. Sobrero, A; Guglielmi, A; Cirillo, M; Recaldin, E; Frassineti, GL; Aschele, C; Ravaioli, A; Testore, P; Caroti, C; Gallo, L; Pessi, MA; Cortesi, E; Turci, D; Grossi, F; Labianca, R
      5-fluorouracil modulated by leucovorin, methotrexate and mitomycin: highlyeffective, low cost chemotherapy for advanced colorectal cancer

      BRITISH JOURNAL OF CANCER
    39. Paradiso, A; Simone, G; De Lena, M; Leone, B; Vallejo, C; Lacava, J; Dellapasqua, S; Daidone, MG; Costa, A
      Expression of apoptosis-related markers and clinical outcome in patients with advanced colorectal cancer

      BRITISH JOURNAL OF CANCER
    40. Shah, MA; Schwartz, GK
      The relevance of drug sequence in combination chemotherapy

      DRUG RESISTANCE UPDATES
    41. Soori, GS; Oldham, RK; Dobbs, TW; Bury, MJ; Church, CK; DePriest, C
      Chemo-biotherapy with 5-fluorouracil, leucovorin, and alpha interferon in metastatic carcinoma of the colon - A cancer biotherapy research group [CBRG] phase II study

      CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS
    42. Min, JS; Kim, NK; Park, JK; Yun, SH; Noh, JK
      A prospective randomized trial comparing intravenous 5-fluorouracil and oral doxifluridine as postoperative adjuvant treatment for advanced rectal cancer

      ANNALS OF SURGICAL ONCOLOGY
    43. Kano, Y; Akutsu, M; Suzuki, K; Yazawa, Y; Tsunoda, S; Furukawa, Y
      Schedule-dependent interaction between raltitrexed and 5-fluorouracil in human colon cancer cell lines in vitro

      ONCOLOGY RESEARCH
    44. Curran, D; Aaronson, N; Standaert, B; Molenberghs, G; Therasse, P; Ramirez, A; Koopmanschap, M; Erder, H; Piccart, M
      Summary measures and statistics in the analysis of quality of life data: an example from an EORTC-NCIC-SAKK locally advanced breast cancer study

      EUROPEAN JOURNAL OF CANCER
    45. Peters, GJ; van Triest, B; Backus, HHJ; Kuiper, CM; van der Wilt, CL; Pinedo, HM
      Molecular downstream events and induction of thymidylate synthase in mutant and wild-type p53 colon cancer cell lines after treatment with 5-fluorouracil and the thymidylate synthase inhibitor raltitrexed

      EUROPEAN JOURNAL OF CANCER
    46. Botwood, N; James, R; Vernon, C; Price, P
      Raltitrexed ('Tomudex') and radiotherapy can be combined as postoperative treatment for rectal cancer

      ANNALS OF ONCOLOGY
    47. Fizazi, K; Zelek, L
      Is 'one cycle every three or four weeks' obsolete? A critical review of dose-dense chemotherapy in solid neoplasms

      ANNALS OF ONCOLOGY
    48. Sobrero, A; Zaniboni, A; Frassineti, GL; Aschele, C; Guglielmi, A; Giuliani, R; Ravaioli, A; Lanfranco, C; Caroti, C; Arnoldi, E; Barni, S; Gallo, L; Pessi, MA; Turci, D; Cortesi, E; Grossi, F; Frontini, L; Piazza, E; Bruzzi, P; Labianca, R
      Schedule specific biochemical modulation of 5-fluorouracil in advanced colorectal cancer: A randomized study

      ANNALS OF ONCOLOGY
    49. Lee, CW; Chi, KN
      The standard of reporting of health-related quality of life in clinical cancer trials

      JOURNAL OF CLINICAL EPIDEMIOLOGY
    50. Rosenthal, DI; Haller, DG; Saltz, L; Semple, D; Minsky, BD
      Postoperative radiation therapy for rectal cancer combined with UFT/leucovorin

      ONCOLOGY-NEW YORK
    51. Bokemeyer, C; Hartmann, JT; Mayer, F; Bohlke, I; Kanz, L; von Pawel, J; Derigs, G; Schroder, M
      UFT/leucovorin plus weekly paclitaxel in the treatment of solid tumors

      ONCOLOGY-NEW YORK
    52. Kornblau, S; Benson, AB; Catalano, R; Champlin, RE; Engelking, C; Field, M; Ippoliti, C; Lazarus, HM; Mitchell, E; Rubin, J; Stiff, PJ; Vokes, E; Wadler, S
      Management of cancer treatment-related diarrhea: Issues and therapeutic strategies

      JOURNAL OF PAIN AND SYMPTOM MANAGEMENT
    53. Lewis, NL; Meropol, NJ
      Oral fluoropyrimidines in cancer treatment

      CANCER INVESTIGATION
    54. Grem, JL; Harold, N; Shapiro, J; Bi, DQ; Quinn, MG; Zentko, S; Keith, B; Hamilton, JM; Monahan, BP; Donavan, S; Grollman, F; Morrison, G; Takimoto, CH
      Phase I and pharmacokinetic trial of weekly oral fluorouracil given with eniluracil and low-dose leucovorin to patients with solid tumors

      JOURNAL OF CLINICAL ONCOLOGY
    55. Madajewicz, S; Hentschel, P; Burns, P; Caruso, R; Fiore, J; Fried, M; Malhotra, H; Ostrow, S; Sugarman, S; Viola, M
      Phase I: Chemotherapy study of biochemical modulation of folinic acid and fluorouracil by gemcitabine in patients with solid tumor malignancies

      JOURNAL OF CLINICAL ONCOLOGY
    56. Savarese, D; Al-Zoubi, A; Boucher, J
      Glutamine for irinotecan diarrhea

      JOURNAL OF CLINICAL ONCOLOGY
    57. Nemunaitis, J; Eager, R; Twaddell, T; Corey, A; Sekar, K; Tkaczuk, K; Thompson, J; Hoff, PM; Pazdur, R
      Phase I assessment of the pharmacokinetics, metabolism, and safety of emitefur in patients with refractory solid tumors

      JOURNAL OF CLINICAL ONCOLOGY
    58. Fizazi, K; Ducreux, M; Ruffie, P; Bonnay, M; Daniel, C; Soria, JC; Hill, C; Fandi, A; Poterre, M; Smith, M; Armand, JP
      Phase I, dose-finding, and pharmacokinetic study of raltitrexed combined with oxaliplatin in patients with advanced cancer

      JOURNAL OF CLINICAL ONCOLOGY
    59. Wilke, H; Stahl, M; Koster, W; Vanhofer, U
      Infusional 5-fluorouracil (5-FU) in solid tumors

      MEDIZINISCHE KLINIK
    60. Schoffski, O
      Economic evaluation in oncology

      MEDIZINISCHE KLINIK
    61. Quietzsch, D; Baronius, W; Jungberg, P; Liebert, A
      Topotecan or a weekly 24-hour infusion in patients with advanced colorectal cancer pretreated with 5-fluorouracil/folinic acid.

      TUMORDIAGNOSTIK & THERAPIE
    62. Eckel, F; Lersch, C; Lippl, F; Assmann, G; Schulte-Frohlinde, E
      Phase II trial of cyclophosphamide, leucovorin, 5-fluorouracil 24-hour infusion and tamoxifen in pancreatic cancer

      JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
    63. Baur, M; Kienzer, HR; Rath, T; Dittrich, C
      Extravasation of oxaliplatin (Eloxatin (R)) - clinical course

      ONKOLOGIE
    64. Vanhoefer, U; Achterrath, W; Wilke, H; Seeber, S
      Preclinical evaluation of irinotecan

      ONKOLOGIE
    65. Schleyer, E; Rudolph, KL; Braess, J; Unterhalt, M; Ehninger, G; Hiddemann, W; Kern, W
      Impact of the simultaneous administration of the (+)- and (-)-forms of formyl-tetrahydrofolic acid on plasma and intracellular pharmacokinetics of (-)-tetrahydrofolic acid

      CANCER CHEMOTHERAPY AND PHARMACOLOGY
    66. Horig, H; Lee, DS; Conkright, W; Divito, J; Hasson, H; LaMare, M; Rivera, A; Park, D; Tine, J; Guito, K; Tsang, KWY; Schlom, J; Kaufman, HL
      Phase I clinical trial of a recombinant canarypoxvirus (ALVAC) vaccine expressing human carcinoembryonic antigen and the B7.1 co-stimulatory molecule

      CANCER IMMUNOLOGY IMMUNOTHERAPY
    67. Cartei, G
      New options for patients previously treated for metastatic colon cancer - platinum salts

      TUMORI
    68. Sdrobolini, A; Contu, A; Massidda, B; Gasperoni, S; Recchia, F; Iannelli, A; Tomao, S; Romiti, A; Raffaele, M; Ortu, S; Campisi, C; Gebbia, V; Olmeo, N; Ionta, MT; Angiona, S; Di Costanzo, F
      5-fluorouracil plus folinic acid with or without ifosfamide in advanced colorectal cancer: A phase II randomized trial

      TUMORI
    69. Tomiak, A; Vincent, M; Kocha, W; Taylor, M; Winquist, E; Keith, B; Sawyer, M; Griffeth, S; Whiston, F; Stitt, L
      Standard dose (Mayo regimen) 5-fluorouracil and low dose folinic acid: Prohibitive toxicity?

      AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
    70. Adams, VR
      Adverse events associated with chemotherapy for common cancers

      PHARMACOTHERAPY
    71. Bogliolo, G; Pannacciulli, I; Desalvo, L; Barsotti, B; Lerza, R; Mencoboni, M; Arboscello, E
      Advanced colorectal cancer: Quality of life and toxicity in patients afterweekly 24-hour continuous infusions of biomodulated 5-fluorouracil

      ANTICANCER RESEARCH
    72. Pocard, M; Bras-Goncalves, R; Hamelin, R; Northover, J; Poupon, MF
      Response to 5-fluorouracil of orthotopically xenografted human colon cancers with a microsatellite instability: Influence of p53 status

      ANTICANCER RESEARCH
    73. Grem, JL
      5-Fluorouracil: forty-plus and still ticking. A review of its preclinical and clinical development

      INVESTIGATIONAL NEW DRUGS
    74. Hoff, PM
      The tegafur-based dihydropyrimidine dehydrogenase inhibitory fluoropyrimidines, UFT/leucovorin (ORZEL (TM)) and S-1: a review of their clinical development and therapeutic potential

      INVESTIGATIONAL NEW DRUGS
    75. Peters, GJ; van der Wilt, CL; van Moorsel, CJA; Kroep, JR; Bergman, AM; Ackland, SP
      Basis for effective combination cancer chemotherapy with antimetabolites

      PHARMACOLOGY & THERAPEUTICS
    76. Topard, D; Hellier, I; Ychou, M; Guillot, B
      Raltitrexed-induced skin reaction

      ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE
    77. Bleiberg, H
      Adjuvant therapy in high-risk colon cancer

      SEMINARS IN ONCOLOGY
    78. Kretzschmar, A; Reichardt, P; Thuss-Patience, PC; Hohenberger, P; Benter, T; Dorken, B; Kohne, CH
      Weekly 24-hour infusion of high-dose 5-fluorouvacil plus folinic acid in combination with mitomycin C for the treatment of advanced gastric cancer

      ONCOLOGY
    79. Fountzilas, G; Zisiadis, A; Dafni, U; Konstantaras, C; Hatzitheoharis, G; Papavramidis, S; Bousoulegas, A; Basdanis, G; Giannoulis, E; Dokmetzioglou, J; Katsohis, C; Nenopoulou, E; Karvounis, N; Briassoulis, E; Aravantinos, G; Kosmidis, P; Skarlos, D; Pavlidis, N
      Fluorouracil and leucovorin with or without interferon alfa-2a as adjuvanttreatment, in patients with high-risk colon cancer - A randomized phase III study conducted by the Hellenic Cooperative Oncology Group

      ONCOLOGY
    80. Adelsberger, H; Quasthoff, S; Grosskreutz, J; Lepier, A; Eckel, F; Lersch, C
      The chemotherapeutic oxaliplatin alters voltage-gated Na+ channel kineticson rat sensory neurons

      EUROPEAN JOURNAL OF PHARMACOLOGY
    81. Tomas, AD
      Advanced rectal cancer. Evolution and current situation of adjuvant therapy

      REVISTA CLINICA ESPANOLA
    82. Terret, C; Erdociain, E; Guimbaud, R; Boisdron-Celle, M; McLeod, HL; Fety-Deporte, R; Lafont, T; Gamelin, E; Bugat, R; Canal, P; Chatelut, E
      Dose and time dependencies of 5-fluorouracil pharmacokinetics

      CLINICAL PHARMACOLOGY & THERAPEUTICS
    83. Rederer, M; Fiebiger, W; Wrba, F; Scheithauer, W
      Fatal liver failure after the administration of raltitrexed for cancer chemotherapy - A report of two cases

      CANCER
    84. Ford, HER; Cunningham, D; Ross, PJ; Rao, S; Aherne, GW; Benepal, TS; Price, T; Massey, A; Vernillet, L; Gruia, G
      Phase I study of irinotecan and raltitrexed in patients with advanced gastrointestinal tract adenocarcinoma

      BRITISH JOURNAL OF CANCER
    85. Braybrooke, JP; Propper, DJ; O'Byrne, KJ; Koukourakis, MI; Patterson, AV; Houlbrook, S; Love, SD; Varcoe, S; Taylor, M; Ganesan, TS; Talbot, DC; Harris, AL
      Induction of thymidine phosphorylase as a pharmacodynamic end-point in patients with advanced carcinoma treated with 5-fluorouracil, folinic acid andinterferon alpha

      BRITISH JOURNAL OF CANCER
    86. Yeh, KH; Yeh, SH; Hsu, CH; Wang, TM; Ma, IF; Cheng, AL
      Prolonged and enhanced suppression of thymidylate synthase by weekly 24-h infusion of high-dose 5-fluorouracil

      BRITISH JOURNAL OF CANCER
    87. Jonker, DJ; Maroun, JA; Kocha, W
      Survival benefit of chemotherapy in metastatic colorectal cancer: a meta-analysis of randomized controlled trials

      BRITISH JOURNAL OF CANCER
    88. Kemeny, NE; Atiq, OT
      Non-surgical treatment for liver metastases

      BEST PRACTICE & RESEARCH IN CLINICAL GASTROENTEROLOGY
    89. Czejka, MJ; Schueller, J; Kletzl, H; Strauch, S; Pietrzak, C
      Clinical significance of pharmacokinetic drug interactions between interferon-alpha and antineoplastic drugs

      BIODRUGS
    90. Lamont, EB; Schilsky, RL
      The oral fluoropyrimidines in cancer chemotherapy

      CLINICAL CANCER RESEARCH
    91. Grem, JL; Sorensen, JM; Cullen, E; Takimoto, CH; Steinberg, SM; Chen, AP; Hamilton, JM; Arbuck, SG; McAtee, N; Lawrence, D; Goldspiel, B; Johnston, PG; Allegra, CJ
      A phase I study of raltitrexed, an antifolate thymidylate synthase inhibitor, in adult patients with advanced solid tumors

      CLINICAL CANCER RESEARCH
    92. Shapiro, JD; Harold, N; Takimoto, C; Hamilton, JM; Vaughn, D; Chen, A; Steinberg, SM; Liewehr, D; Allegra, C; Monahan, B; Lash, A; Grollman, F; Flemming, D; Behan, K; Johnston, PG; Haller, D; Quinn, M; Morrison, G; Grem, JL
      A pilot study of interferon alpha-2a, fluorouracil, and leucovorin given with granulocyte-macrophage colony stimulating factor in advanced gastrointestinal adenocarcinoma

      CLINICAL CANCER RESEARCH
    93. Cao, SS; McGuire, JJ; Rustum, YM
      Antitumor activity of ZD1694 (tomudex) against human head and neck cancer in nude mouse models: Role of dosing schedule and plasma thymidine

      CLINICAL CANCER RESEARCH
    94. Takimoto, CH; Yee, LK; Venzon, DJ; Schuler, B; Grollman, F; Chabuk, C; Hamilton, JM; Chen, AP; Allegra, CJ; Green, JL
      High inter- and intrapatient variation in 5-fluorouracil plasma concentrations during a prolonged drug infusion

      CLINICAL CANCER RESEARCH
    95. Bavisotto, LM; Patel, NH; Althaus, SJ; Coldwell, DM; Nghiem, HV; Thompson, T; Storer, B; Thomas, CR
      Hepatic transcatheter arterial chemoembolization alternating with systemicprotracted continuous infusion 5-fluorouracil for gastrointestinal malignancies metastatic to liver: A phase II trial of the Puget sound oncology consortium (PSOC 1104)

      CLINICAL CANCER RESEARCH
    96. Ornstein, DL; Pipas, JM; Rigas, JR
      Recent advances in cancer chemotherapy

      ACADEMIC RADIOLOGY
    97. Baron, MG; Espinosa, E; Feliu, J; Espinosa, J; Lomas, M; Zamora, P; Jalon, JI; Puerto, JM; Blanco, E; de Castro, J; Ordonez, A; Casado, E
      UFT-LV as adjuvant therapy for Dukes' B2-C colon cancer

      GI CANCER
    98. Hausmaninger, H; Moser, R; Samonigg, H; Mlineritsch, B; Schmidt, H; Pecherstorfer, M; Fridrik, M; Kopf, C; Nitsche, D; Kaider, A; Ludwig, H
      Biochemical modulation of 5-fluorouracil by leucovorin with or without interferon-alpha-2c in patients with advanced colorectal cancer: Final resultsof a randomised phase III study

      EUROPEAN JOURNAL OF CANCER
    99. Sobrero, AF
      Does biomodulation of 5-fluorouracil improve results? Pro

      EUROPEAN JOURNAL OF CANCER
    100. Herrmann, R
      Does biomodulation of 5-fluorouracil improve results? Contra

      EUROPEAN JOURNAL OF CANCER


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 20/10/20 alle ore 07:40:59